Target Name: MIR1302-8
NCBI ID: G100302223
Review Report on MIR1302-8 Target / Biomarker Content of Review Report on MIR1302-8 Target / Biomarker
MIR1302-8
Other Name(s): Hsa-mir-1302-8 | hsa-mir-1302-8 | MIRN1302-8 | MicroRNA 1302-8 | hsa-miR-1302 | microRNA 1302-8

MIR1302-8: A Drug Target / Disease Biomarker

MIR1302-8 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and kidneys. It is a member of the MIR family of cytoskeletal proteins, which are involved in the regulation of cell shape and movement.

One of the unique features of MIR1302-8 is its ability to interact with a variety of different cytoskeletal proteins. This makes it a promising target for researchers who are interested in understanding the role of these proteins in various biological processes.

In addition to its potential as a drug target, MIR1302-8 has also been identified as a potential biomarker for a variety of diseases. For example, studies have shown that MIR1302-8 levels are elevated in the brains of individuals with Alzheimer's disease, which is a leading cause of dementia.

This suggests that MIR1302-8 may be a useful diagnostic or therapeutic target for the treatment of Alzheimer's disease and other similar conditions.

More research is needed to fully understand the role of MIR1302-8 in these diseases, as well as its potential as a drug or biomarker. However, its unique structure and ability to interact with a variety of different cytoskeletal proteins make it an intriguing target for research in this field.

Protein Name: MicroRNA 1302-8

The "MIR1302-8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1302-8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1